Breast Neoplasms: all 12,820 studies
Page 93 of 129. Open to participants first (2,923), then studies with results posted, then the rest; newest registration first within each.
- A Phase II, Single-Arm Trial of Poziotinib as Salvage Treatment in Patients With Metastatic Breast Cancer Who Has HER2 or EGFR Mutation or Activated AR or EGFR PathwayCompletedNCT02544997Phase 2
- Comparing 3-D Printed vs Standard Bolus for Breast Cancer Chest Wall RadiotherapyCompletedNCT02544945Not applicable
- Vinorelbine/Gemcitabine Versus Vinorelbine/Cisplatin in Metastatic Breast CancerStatus unknownNCT02544243Phase 2
- Genotype and Phenotype in Early Onset Breast Cancer in Young Women on the Two Shores of the Mediterranean SeaTerminatedNCT02541188
- A Trial of the ForeCYTE Breast Aspirator for Cytological Testing of Nipple Aspirate Fluid in Women 30-55 Years OldWithdrawnNCT02539615Phase 3
- The Clinical Significance of Cellular Immune Adjuvant Therapy of Triple Negative Breast CancerWithdrawnNCT02539017Phase 2
- Impact of Omega 3 Fatty Acid Supplementation on Aromatase in Obese SubjectsCompletedNCT02538484Early Phase 1
- Study of the Impact of Everolimus Treatment on Lymphocytes NK (Natural Killer) Development and Functions for Patients With a Metastatic Breast Cancer (HR+ / HER2/Neu Negative)CompletedNCT02536625
- Neoadjuvant Aromatase Inhibitor(AI) With Ovarian Suppression Versus Chemotherapy in Premenopausal Breast Cancer PatientsTerminatedNCT02532400Phase 3
- Comparison of Single-Agent Carboplatin vs the Combination of Carboplatin and Everolimus for the Treatment of Advanced Triple-Negative Breast CancerCompletedNCT02531932Phase 2
- Evaluation of Pharmacodynamic Effects of IT-pIL12-EP in Patients With TNBCCompletedNCT02531425Phase 1
- "Neo-Adjuvant Treatment With Palbociclib: Effect on Ki67 and Apoptosis Before, During and After Treatment "CompletedNCT02530424Phase 2
- Multiple B-value Diffusion-weighted Imaging(DWI) in Evaluation of Breast LesionsStatus unknownNCT02529384
- Choices for Latinas and Clinical TrialsCompletedNCT02529280Not applicable
- A Survey of Breast Cancer Patients With Metastatic Bone Disease Receiving Oral IbandronateCompletedNCT02528747
- The Effect of Resistive Exercise on Forearm Blood Flow and Tissue Oxygenation Among Breast Cancer Survivors With or at Risk for Breast Cancer-related Lymphoedema (BCRL)CompletedNCT02527889Not applicable
- Dose Dense Chemotherapy With Lipegfilgrastim Support in Early Breast CancerCompletedNCT02527317
- Nipple Delay Prior to Nipple Sparing Mastectomy: A Pilot RCTWithdrawnNCT02526719Not applicable
- Continues Cicatricial Perfusion of Ropivacaine Versus Placebo After Mastectomy : Rehabilitation After TreatmentTerminatedNCT02525211Phase 3
- Effectiveness of DIM Supplements to Increase 2-OHE1/16 RatioCompletedNCT02525159Phase 3
- Safety and Tolerability of MSI-1436C in Metastatic Breast CancerTerminatedNCT02524951Phase 1
- SMS Reminders to Improve Medication Adherence of Aromatase InhibitorsCompletedNCT02524548Not applicable
- HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA）for Breast CancerCompletedNCT02523417Phase 1/2
- OptiTrain - Optimal Training Women With Breast CancerCompletedNCT02522260Not applicable
- Support Group Program in Improving Quality of Life in Underserved Urban Latina Breast Cancer SurvivorsCompletedNCT02521961Not applicable
- SurgiMend® vs. Strattice™ in Direct to Implant Breast Reconstruction- A Prospective Randomized TrialCompletedNCT02521623Not applicable
- Intravenous Ascorbic Acid in Women Receiving Adjuvant or Neo-Adjuvant Chemotherapy for Early Stage Breast CancerWithdrawnNCT02521077Phase 2
- Preventive Intervention Against Lymphedema After Breast Cancer SurgeryCompletedNCT02518477Not applicable
- Genetic Risk Estimation of Breast Cancer Prior to Preventive Medication UptakeCompletedNCT02517593Phase 1/2
- Vascular Changes Due to Different Treatments of Lymphedema Secondary to Postoperative Breast CancerStatus unknownNCT02517086Not applicable
- An Investigation of Chemotherapy Induced Cognitive Impairments in Breast Cancer SurvivorsCompletedNCT02515487Not applicable
- Hypofractionated Regional Nodal Irradiation Clinical Trial for Women With Breast CancerActive, not recruitingNCT02515110Not applicable
- Microwave Radiometry for the Diagnosis and Monitoring of Breast CancerWithdrawnNCT02514837
- A Phase III Trial of Pertuzumab Retreatment in Previously Pertuzumab Treated Her2-Positive Advanced Breast CancerCompletedNCT02514681Phase 3
- A Dose-escalation Study of ARX788, IV Administered in Subjects With Advanced Cancers With HER2 ExpressionTerminatedNCT02512237Phase 1
- Trial of Afatinib With Paclitaxel for Neoadjuvant Therapy of TNBC and Research of Biomarkers of AfatinibStatus unknownNCT02511847Phase 2
- Maintenance Aromatase Inhibitors (AIs)+ Everolimus vs AIs in Hormone Receptor Positive Metastatic Breast Cancer PatientsCompletedNCT02511639Phase 3
- Circadian Thermal Sensing to Detect Breast DiseaseStatus unknownNCT02511301Phase 1/2
- A Study on Neoadjuvant Therapy for Her-2 Positive Breast Cancer and the Prognosis by Detecting CTCsStatus unknownNCT02510781Phase 2
- Monitoring Neoadjuvant Chemotherapy Response in Breast Cancer Patients Using Diffuse Optical Spectroscopic ImagingCompletedNCT02510456
- The Plan and Stand Study: Reducing Sitting Time in Breast Cancer SurvivorsCompletedNCT02510430Not applicable
- Study of Body Composition in Patients Treated by Adjuvant Hormonal Therapy for Breast Cancer (MetaCa2)CompletedNCT02509871Not applicable
- Neoadjuvant Toremifene With Melatonin or Metformin in Locally Advanced Breast CancerStatus unknownNCT02506790Phase 2
- Neoadjuvant FDC With Melatonin or Metformin for Locally Advanced Breast Cancer.Status unknownNCT02506777Phase 2
- Phosphatidylinositol 3-kinase (PI3K) Alpha iNhibition In Advanced Breast CancerCompletedNCT02506556Phase 2
- Treatment Pathway of Patients Suffering From a Breast Cancer Related LymphoedemaCompletedNCT02506530Not applicable
- Late Toxicity in Breast Cancer Patients Treated With Breast-conserving Surgical Procedures and Radiotherapy Using the Simultaneous Integrated Boost TechniqueCompletedNCT02505906
- A Data Collection Study for the Evaluation of a Novel Infra-red Breast Imaging System for Risk AssessmentWithdrawnNCT02505698
- A Study to Assess the Efficacy of Rucaparib in Metastatic Breast Cancer Patients With a BRCAness Genomic SignatureCompletedNCT02505048Phase 2
- Nivolumab After Induction Treatment in Triple-negative Breast Cancer (TNBC) PatientsActive, not recruitingNCT02499367Phase 2
- Biomarkers and Cardiac MRI as Early Indicators of Cardiac Exposure Following Breast RadiotherapyCompletedNCT02496260
- Exploratory Study of Safety and ex Vivo Fluorescence of BLZ-100 in Adult Subjects With Solid Tumors Undergoing SurgeryCompletedNCT02496065Phase 1
- Analgesic Effects of Ultrasound Guided PEC Blocks on Analgesic Opioid Consumption of Cancer Surgery PatientsCompletedNCT02495363
- Initial Assessment of an Internet-based Symptom Management Intervention in Early Stage Breast CancerCompletedNCT02495155Not applicable
- The Canadian/US Integrative Oncology StudyCompletedNCT02494037
- A Multicenter Study of Clinical Epidemiology of Breast Cancer in Shaanxi Province of ChinaStatus unknownNCT02493569
- Impact of LOFT Therapy™ on Breast Cancer SurvivorsCompletedNCT02491957Not applicable
- Immunotherapy Combined With Capecitabine Versus Capecitabine Monotherapy in Advanced Breast CancerActive, not recruitingNCT02491697Phase 2
- Recombinant Human Endostatin (EndostarTM) Injection in Treatment of Recurrent Metastatic Breast CancerStatus unknownNCT02489409Phase 2
- Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast CancerActive, not recruitingNCT02488967Phase 3
- Decision Aids for Tamoxifen Treatment in Breast Cancer PatientsStatus unknownNCT02488603Not applicable
- A Study of Liposomal Doxorubicin+Docetaxel+Trastuzumab+Metformin in Operable and Locally Advanced HER2 Positive Breast CancerCompletedNCT02488564Phase 2
- Comparison of Preoperative ABUS and MRI in Newly Diagnosed Breast Cancer PatientsStatus unknownNCT02488187Not applicable
- Biomarkers of Neuropathic Pain in Women Treated for Breast CancerCompletedNCT02487524Not applicable
- A Pragmatic Trial of Ambulatory Toxicity Management in Patients Receiving Adjuvant or Neo-adjuvant Chemotherapy for Early Stage Breast CancerCompletedNCT02485678Not applicable
- Identifying Subgroups With High Cardiovascular Risk in Breast Cancer SurvivorsStatus unknownNCT02485626
- Phase I/II Study of the Anti-Programmed Death Ligand-1 Durvalumab Antibody (MEDI4736) in Combination With Olaparib and/or Cediranib for Advanced Solid Tumors and Advanced or Recurrent Ovarian, Triple Negative Breast, Lung, Prostate and Colorectal Can...Active, not recruitingNCT02484404Phase 1/2
- Bone Health Management for Women Diagnosed With Breast CancerCompletedNCT02484131Not applicable
- Analgesic Effect to Postoperative Pain After Mastectomy: Ultrasound-guided Serratus Anterior Plane BlockCompletedNCT02483923Not applicable
- Dose Optimization of Rosuvastatin in Early Stage and Metastatic Estrogen Receptor Positive Breast Cancer Patients on Endocrine TherapyWithdrawnNCT02483871Phase 1
- Gonadotropin-Releasing Hormone Agonist for the Preservation of Ovarian Function During Chemotherapy in Premenopausal Breast CancerCompletedNCT02483767Phase 3
- Patient Navigation and Tailored Treatment Planning in Latina Patients With Breast CancerTerminatedNCT02483377
- Trial of Chidamide in Combination With Exemestane in Patients With Advanced Breast CancerCompletedNCT02482753Phase 3
- Moving Forward: A Weight Loss Intervention for African-American Breast Cancer SurvivorsCompletedNCT02482506Not applicable
- Surgical Trial to Evaluate the Impact of a Lymphoscintigraphy Prior to Sentinel Node Biopsy in Early Breast CancerCompletedNCT02481128Not applicable
- Silent Breast Cancer A Study of the Disease Prevalence Held by Imaging Guided Biopsies in Autopsy SpecimensStatus unknownNCT02480933Not applicable
- Clinical Trial With Two Physical Therapy Protocols After Breast Cancer Surgery and Immediate ReconstructionCompletedNCT02480842Not applicable
- Cognitive Sequelae of Adjuvant Endocrine Therapy for the Treatment of Breast Cancer in Older WomenCompletedNCT02480218
- Clinical Application of Dual Sentinel Lymph Node Staining Method in Breast Cancer PatientsCompletedNCT02479997Phase 2
- Effects of an ICT-platform for Assessment and Management of Patient-reported Symptoms During Treatment for Breast CancerCompletedNCT02479607Not applicable
- Wound Infections in Breast Cancer Surgery After Preoperative Skin Preparation With Chlorhexidine vs. Povidone-iodineCompletedNCT02479347Phase 4
- Type I-Polarized Autologous Dendritic Cell Vaccine With Tumor Blood Vessel Antigen-Derived Peptides in Metastatic Breast Cancer PatientsCompletedNCT02479230Phase 1
- Study Evaluating Hemay022 In Subjects With HER2-Positive Advanced Breast CancerCompletedNCT02476539Phase 1
- Hypofractionation With Simultaneous Integrated Boost vs. Standard Fractionation in Early Breast CancerActive, not recruitingNCT02474641Not applicable
- Phase II Study for Solid Metastatic TumorsCompletedNCT02474186Phase 2
- Onalespib and Paclitaxel in Treating Patients With Advanced Triple Negative Breast CancerTerminatedNCT02474173Phase 1
- EXercise Influence on Taxane Side Effects (EXIT) StudyCompletedNCT02473861Not applicable
- Clinical Application of Near-infrared Fluorescence Guided Localization on Breast Surgery in Breast CancerStatus unknownNCT02473159Phase 2
- Study of ESR1 Mutations in Metastatic Breast CancerCompletedNCT02473120Not applicable
- TOxicity After Radiotherapy in breAst CancEr Survivors (ThORACeS) - A Retrospective Cohort StudyCompletedNCT02471079
- Genomic and Proteomic Profiling Targets Influenced Treatment in Metastatic Breast CancerWithdrawnNCT02470819Not applicable
- Effect of GM1 in Prevention of Taxanes Induced Neurotoxicity in Operable Breast CancerCompletedNCT02468739Phase 3
- Efficacy and Safety Study With MYL-1401H and NeulastaCompletedNCT02467868Phase 3
- Comparison of Axillary Sentinel Lymph Node Biopsy Versus no Axillary SurgeryActive, not recruitingNCT02466737Not applicable
- Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)Active, not recruitingNCT02465060Phase 2
- Psycho-esthetic Impact of Tattoo Technology as Part of Mammary Reconstruction After Surgery Against Breast CancerCompletedNCT02464982
- Breast-Conserving Therapy in Patients With Triple-Negative Breast CancerStatus unknownNCT02464774Not applicable
- Mobile Health (mHealth) Black Women With Breast CancerCompletedNCT02463474Not applicable
- Effect of PPARγ2 Polymorphism and NSAIDs on Acute Alcohol-induced Changes in Serum Estrogens Among Post-menopausal WomenCompletedNCT02463383Early Phase 1
- Enhancing Management of Chronic Pain and Symptoms Among Women Treated for Breast Cancer (Lymph-Flow)CompletedNCT02462226Not applicable